{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:21:33Z","timestamp":1794608493492,"version":"4.9.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.047","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T22:47:10Z","timestamp":1664232430000},"page":"6362-6366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-5044","authenticated-orcid":false,"given":"Minoru","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-8489","authenticated-orcid":false,"given":"Yoshinori","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8466-3957","authenticated-orcid":false,"given":"Hiroshi","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-5901","authenticated-orcid":false,"given":"Hiroshi","family":"Bannai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-2484","authenticated-orcid":false,"given":"Ann","family":"Cullinane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5157","authenticated-orcid":false,"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6154-2263","authenticated-orcid":false,"given":"Manabu","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.047_b0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038331","article-title":"Equine Influenza","volume":"12","author":"Chambers","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2022.09.047_b0010","series-title":"The Official","first-page":"21","article-title":"The World Organization for Animal Health (OIE). OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition","volume":"2020-1","year":"2020"},{"key":"10.1016\/j.vaccine.2022.09.047_b0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1292\/jvms.70.623","article-title":"Epidemic of equine influenza among vaccinated racehorses in Japan in 2007","volume":"70","author":"Yamanaka","year":"2008","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2022.09.047_b0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00705-011-1000-5","article-title":"Antigenic and genetic analysis of H3N8 influenza viruses isolated from horses in Japan and Mongolia, and imported from Canada and Belgium during 2007\u20132010","volume":"156","author":"Motoshima","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2022.09.047_b0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1292\/jvms.16-0558","article-title":"Update of inactivated equine influenza vaccine strain in Japan","volume":"79","author":"Gamoh","year":"2017","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2022.09.047_b0030","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.09.047_b0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/evj.13431","article-title":"Growth properties and immunogenicity of a virus generated by reverse genetics for an inactivated equine influenza vaccine","volume":"54","author":"Ohta","year":"2022","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2022.09.047_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jevs.2021.103860","article-title":"Antibody responses to a reverse genetics-derived bivalent inactivated equine influenza vaccine in Thoroughbred horses","volume":"109","author":"Ohta","year":"2022","journal-title":"J Equine Vet Sci"},{"key":"10.1016\/j.vaccine.2022.09.047_b0045","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00705-019-04328-4","article-title":"A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain","volume":"164","author":"Nemoto","year":"2019","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2022.09.047_b0050","doi-asserted-by":"crossref","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: Global initiative on sharing all influenza data - from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2022.09.047_b0055","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.1038\/ncomms9148","article-title":"Development of high-yield influenza A virus vaccine viruses","volume":"6","author":"Ping","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.09.047_b0060","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2022.09.047_b0065","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/jgv.0.001325","article-title":"Mutated influenza A virus exhibiting reduced susceptibility to baloxavir marboxil from an experimentally infected horse","volume":"100","author":"Nemoto","year":"2019","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.09.047_b0070","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2022.09.047_b0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/evj.13062","article-title":"Serum amyloid A in equine health and disease","volume":"51","author":"Witkowska-Pi\u0142aszewicz","year":"2019","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2022.09.047_b0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/am.16.4.563-568.1968","article-title":"Induction of an inhibitor of influenza virus hemagglutination by treatment of serum with periodate","volume":"16","author":"Beardmore","year":"1968","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2022.09.047_b0085","unstructured":"The World Organization for Animal Health (OIE). Chapter 3.5.7. Equine influenza (infection with equine influenza virus). In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2019, Paris: OIE; 2019. p. 1\u201319."},{"key":"10.1016\/j.vaccine.2022.09.047_b0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1292\/jvms.10-0408","article-title":"Antibody responses induced by Japanese whole inactivated vaccines against equine influenza virus (H3N8) belonging to Florida sublineage clade2","volume":"73","author":"Yamanaka","year":"2011","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2022.09.047_b0095","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/evj.12290","article-title":"The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines","volume":"47","author":"Yamanaka","year":"2015","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2022.09.047_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1294\/jes.23.17","article-title":"Time-related pathological changes in horses experimentally inoculated with equine influenza A virus","volume":"23","author":"Muranaka","year":"2012","journal-title":"J Equine Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:06Z","timestamp":1759403946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":20,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22011550"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}